Contract development and manufacturing organization (CDMO) Sterling Pharma Solutions is investing £6 million into a new facility at its UK site to strengthen and expand its milling, micronization and solid form capabilities. The 40-acre site in Dudley, North East England, will meet growing demand for pharmaceutical API particle size control technology, as well as expanding Sterling’s laboratory capabilities to provide a full solid form offering including polymorph screening, salt selection an...